NCT05420935View on ClinicalTrials.gov

Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

April 12, 2033

Study Completion Date

December 15, 2033

Conditions
Hypersensitivity, ImmediatePeri-operative InjuryAntibiotic AllergyAntibody Hypersensitivity
Interventions
DIAGNOSTIC_TEST

IgG group

"Will be performed :~* a blood sampling of 5 ml (for realization of a basophil activation test)~* a blood sampling of 250 ml"

DIAGNOSTIC_TEST

IgE group

"Will be performed :~* a blood sampling of 5 ml (for realization of a basophil activation test)~* a bone marrow sampling"

DIAGNOSTIC_TEST

IgG group + IgE group

"* a blood sampling of 5 ml (for realization of a basophil activation test)~* a blood sampling of 250 ml~* a bone marrow sampling"

Trial Locations (1)

75018

RECRUITING

Hôpital Bichat claude Bernard, Paris

Sponsors

Collaborators (1)

Institut Pasteur
All Listed Sponsors
collaborator

Institut Pasteur

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05420935 - Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room | Biotech Hunter | Biotech Hunter